Analyst Research Report Snapshot


Venus Remedies Limited




MarketLine (a Datamonitor Company)


15 Apr 2014





Companies referenced:


Available for Immediate Download

Venus Remedies Limited - Company Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, product and service offerings, and corporate actions, providing a 360° view of the company. Features: - Detailed information on Venus Remedies Limited required for business and competitor intelligence needs - Intelligence on Venus Remedies Limited’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors - News about Venus Remedies Limited, such as business expansion, restructuring, and contract wins - Large number of easy-to-grasp charts and graphs that present important data and key trends Highlights: Venus Remedies (Venus) is a research based pharmaceutical company, engaged in manufacturing fixed dosage injectables, used in therapeutic segments like anti-infective, oncology, cardiovascular and neurology. The company's products include Mebatic, Zydotum, Supime, Pirotum, and Neurotol. The company operates in India, Germany, Vietnam, Kenya, and Colombia. It is headquartered in Panchkula, India. The company recorded revenues of INR4,591 million (approximately $84.6 million) in the fiscal year ended March 2012, an increase of 14.3% over 2011. The company's operating profit was INR871.2 million (approximately $16 million) in fiscal 2012, an increase of 5.7% over 2011. Its net profit was INR571.5 million (approximately $10.5 million) in fiscal 2012, an increase of 14.2% over 2011. Reasons to Purchase: - Gain understanding of Venus Remedies Limited the company and its strategies - Track strategic initiatives of the company and latest corporate news and actions - Assess Venus Remedies Limited as a prospective partner, vendor or supplier - Support sales activities by understanding your customers' businesses better - Stay up to date on Venus Remedies Limited your competitors' business structure, strategy and prospects

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.